Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities Source: Eur Respir J 2007; 29: 156-178 Year: 2007
Is obstructive sleep apnoea a risk factor for cardiovascular disease? Source: Annual Congress 2005 - Cardiovascular disease and obstructive sleep apnoea: risks and remedy Year: 2005
Sleep apnoea and driving risk: the need for regulation Source: Eur Respir Rev 2015; 24: 602-606 Year: 2015
Does the neutrophil-to-lymphocyte ratio have any importance between subjects with obstructive sleep apnea syndrome with obesity and without obesity? Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea Year: 2016
Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment Source: Eur Respir J 2002; 20: 1511-1518 Year: 2002
Physical activity: the key to cardiometabolic risk reduction in obstructive sleep apnoea Source: Eur Respir J, 52 (4) 1801775; 10.1183/13993003.01775-2018 Year: 2018
Combination between sleep apnoea and COPD: a synergistic risk for cardiovascular diseases? Source: Sleep and Breathing Conference 2017 Year: 2017
Association between childhood obstructive sleep apnoea and risk of early osteoporosis. Source: International Congress 2019 – Evaluation of breathing in children when they are asleep, healthy or ill Year: 2019
Sleep apnoea and risk of post-operative infection: beyond cardiovascular impact Source: Eur Respir J , 49 (4) 1700292; DOI: 10.1183/13993003.00292-2017 Year: 2017
Late Breaking Abstract: Exposure to passive smoking as a risk factor for developing obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2010 - Passive smoking Year: 2010
Obstructive sleep apnea, cardiometabolic risk, and levels of physical activity in Chilean adults Source: International Congress 2017 – Risk factors: symptomatology and diagnostic approaches for obstructive sleep apnoea Year: 2017
Pharmacological management of sleep-disordered breathing Source: Eur Respir Mon 2010; 50: 321-339 Year: 2010
Treatment effects of sleep apnoea: where are we now? Source: Eur Respir Rev 2007; 16: 146-168 Year: 2007
Obstructive sleep apnoea: who should be treated? Source: Annual Congress 2005 - PG12 - Sleep-related problems: treatment of obstructive sleep apnoea - current concepts and perspectives Year: 2005
Understanding the pathophysiological mechanisms of cardiometabolic complications in obstructive sleep apnoea: towards personalised treatment approaches Source: Eur Respir J, 56 (2) 1902295; 10.1183/13993003.02295-2019 Year: 2020
Metabolic consequences in obstructive sleep apnoea Source: Annual Congress 2006 - PG9 - Obstructive sleep apnoea: current pathophysiological, clinical and therapeutic concepts Year: 2006
Sleep-disordered breathing: a new risk factor of suspected fatty liver disease in overweight children and adolescents? Source: Annual Congress 2007 - Sleep apnoea in childhood Year: 2007
Gender differences in global cardiovascular risk factors of obstructive sleep apnea patients Source: Eur Respir J 2006; 28: Suppl. 50, 413s Year: 2006
Menopause and cardiovascular risk factors in sleep apnea Source: Eur Respir J 2006; 28: Suppl. 50, 200s Year: 2006